ROMPUN 20MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
ROMPUN 20MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Authorised
- Xylazine hydrochloride
Product identification
Medicine name:
ROMPUN 20MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- Xylazine hydrochloride
Target species:
-
Cat
-
Dog
-
Cattle
-
Horse
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Xylazine hydrochloride20.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cat
-
Not applicableno withdrawal periodΔεν εφαρμόζεται
-
-
Dog
-
Not applicableno withdrawal periodΔεν εφαρμόζεται
-
-
Cattle
-
Meat and offal1day
-
Milk12hour
-
-
Horse
-
Meat and offal1day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 85083/02-12-2011/K-0035001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet